Appropriate insulin initiation dosage for insulin-naive type 2 diabetes outpatients receiving insulin monotherapy or in combination with metformin and/or pioglitazone

Chinese Medical Journal

Volumn 123, Issue 24, 2010, Pages 3684-3688

  Liao, Lin ^a   Yang, Ming ^a,b   Qiu, Lu Lu ^a   Mou, Ya Ru ^a   Zhao, Jia Jun ^a   Dong, Jian Jun ^c  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^c SHANDONG UNIVERSITY   (China)

Author keywords

Initiation dosage; Insulin; Metformin; Pioglitazone; Type 2 diabetes

Indexed keywords

GLUCOSE; INSULIN; METFORMIN; PIOGLITAZONE;

ADULT; AGE; ARTICLE; BODY WEIGHT; CHINESE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DOSE RESPONSE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT CARE; RANDOMIZED CONTROLLED TRIAL; TREATMENT PLANNING;

ADULT; AGED; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LINEAR MODELS; MALE; METFORMIN; MIDDLE AGED; OUTPATIENTS; REGRESSION ANALYSIS; THIAZOLIDINEDIONES;

EID: 78650628091     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2010.24.031     Document Type: Article

References (16)

1. Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabetes Care 2009; 32: 193-203.
2. Hirsch IB, Bergenstal RM, Parkin C G, Wright E Jr, Buse JB. A real-world approach to insulin therapy in primary care practice. Clin Diabetes 2005; 23: 78-86.
3. Polonsky WH, Jackson RA. What's so tough about taking insulin? Addressing the problem of psychological insulin resistance in type 2 diabetes. Clin Diabetes 2004; 22: 147-150.
4. Rosenstock J, Riddle MC. Insulin therapy in type 2 diabetes. In: Cefalu WT, Gerich JE, LeRoith D, eds. The CADRE Handbook of Diabetes Management. New York, NY: Medical Information Press; 2004: 145-168.
5. Davis S, Alonso MD. Hypoglycemia as a barrier to glycemic control. J Diabetes Complications 2004: 18: 60-68.
6. The American Diabetes Association. Executive Summary: Standards of Medical Care in Diabetes - 2009. Diabetes Care 2009; 32: s6-s12.
7. The American Association of Clinical Endocrinologists Medical Guidelines for the Management of Diabetes Mellitus: the AACE system of intensive diabetes self-management--2000 update. Endocr Pract 2000; 6: 43-84.
8. Raskin P, Allen E, Hollander P, Lewin A, Gabbay RA, Hu P, et al. Initiating insulin therapy in type 2 diabetes. Diabetes Care 2005; 28: 260-265.
9. Maedler K, Donath MY. Beta-cells in type 2 diabetes: a loss of function and mass. Horm Res 2004; 62: 67-73.
10. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001; 108: 1167-1174.
11. Hundal RS, Inzucchi SE. Metformin: new understandings, new uses. Drugs 2003; 63: 1879-1894.
12. Girard J. Mechanisms of action of thiazolidinediones. Diabetes Metab 2001; 27: 271-278.
13. Lebovitz HE, Banerji MA. Insulin resistance and its treatment by thiazolidinediones. Recent Prog Horm Res 2001; 56: 265-294.
14. Fonseca V, Rosenstock J, Patwardhan R, Salzman A. Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial. JAMA 2000; 283: 1695-1702.
15. Einhorn D, Rendell M, Rosenzweig J, Egan JW, Mathisen AL, Schneider RL. Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: a randomized, placebo-controlled study. The Pioglitazone 027 Study Group. Clin Ther 2000; 22: 1395-1409.
16. Bell DS, Ovalle F. Long-term efficacy of triple oral therapy for type 2 diabetes mellitus. Endocr Pract 2002; 8: 271-275.